WIRED Science on Nostr: The FDA Just Rejected a Bid for MDMA’s Approval to Treat PTSD The agency has asked ...
The FDA Just Rejected a Bid for MDMA’s Approval to Treat PTSD
The agency has asked drugmaker Lykos Therapeutics to run an additional study on the use of the psychedelic drug in patients with post-traumatic stress disorder, pushing back its next proposal by years.
https://www.wired.com/story/fda-rejects-mdma-ptsd-treatment/Published at
2024-08-09 23:00:15Event JSON
{
"id": "97c039c69fa83484b74a0a3a493b9d377fbaacf0db0ac58048c223e1555d5156",
"pubkey": "111cd02902d3e849b9cf3879efafdfd4587d8b51b42215d9bee8c78160796480",
"created_at": 1723244415,
"kind": 1,
"tags": [
[
"guid",
"66b3c1afc383e8e7b96bbec4"
]
],
"content": "The FDA Just Rejected a Bid for MDMA’s Approval to Treat PTSD\n\nhttps://media.wired.com/photos/66b3c8dd056864a0e108c747/master/pass/MDMA-FDA-Sci-1497001987.jpg\n\nThe agency has asked drugmaker Lykos Therapeutics to run an additional study on the use of the psychedelic drug in patients with post-traumatic stress disorder, pushing back its next proposal by years.\n\nhttps://www.wired.com/story/fda-rejects-mdma-ptsd-treatment/",
"sig": "93801fa21bc05f24ad20864435fd0cddcf2ccd16f160362dab91ae42a064cb4f6a6fba2487d175a97bdcb46e189b2f37381b594bbdd06497af1e3be306bbdf79"
}
